C84.7A
BillableAnaplastic large cell lymphoma, ALK-negative, breast
HCC Category Mapping
What This Code Means
A type of aggressive lymphoma (cancer of immune cells) that starts in the breast and does not have a specific genetic marker called ALK.
Coding Tips
- •Verify the ALK-negative status is documented in the pathology report before assigning this code
- •This code is specific to breast involvement; confirm the primary site is the breast and not metastatic disease
Clinical Significance
Anaplastic large cell lymphoma, ALK-negative, involving the breast is a clinically significant code that specifically captures breast implant-associated ALCL (BIA-ALCL) and other breast-based ALCL. BIA-ALCL is a recognized entity associated with textured breast implants and typically presents as a late-onset periprosthetic seroma or mass. Early-stage BIA-ALCL confined to the capsule has excellent prognosis with implant removal, while advanced disease requires systemic therapy.
Documentation Requirements
- ✓Pathology confirming ALCL with CD30 positivity and ALK-negative status in breast tissue
- ✓Documentation of breast implant history if applicable
- ✓Description of presentation (seroma, mass, capsular involvement)
- ✓Staging of breast involvement (confined to capsule vs. beyond capsule vs. disseminated)
- ✓Bilateral implant status documented if relevant